Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC

Central nervous system (CNS) metastases occur frequently in oncogene-driven non-small cell lung cancer (NSCLC). Standard treatment approaches can potentially delay systemic treatment (surgical intervention) or result in neurocognitive impairment (radiotherapy). Recently, next-generation tyrosine kin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gal, Omer, Dudnik, Elizabeth, Rotem, Ofer, Finkel, Inbar, Peretz, Idit, Zer, Alona, Mandel, Jacob, Amiel, Alexandra, Siegal, Tali, Bar, Jair, Lobachov, Anastasiya, Yust, Shlomit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486631/
https://www.ncbi.nlm.nih.gov/pubmed/32963526
http://dx.doi.org/10.1155/2020/1980891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486631/
https://www.ncbi.nlm.nih.gov/pubmed/32963526
http://dx.doi.org/10.1155/2020/1980891

Ejemplares similares